Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China

Figure 4 Incidence rate of metabolic dysfunction-associated fatty liver disease under the cumulative effects of excess high-normal alanine aminotransferase levels and a single excess high-normal alanine aminotransferase level occurrence in different groups. The incidence rate of metabolic dysfunction-associated fatty liver disease showed a linear increasing trend in the cumulative excess high-normal alanine aminotransferase (ehALT) levels groups, while a single ehALT occurrence did not show a linear increasing trend in different groups. MAFLD: Metabolic dysfunction-associated fatty liver disease; ehALT: Excess high-normal alanine aminotransferase.